APA (7th ed.) Citation

Oppelt, P., Ley, J., Auberle, C., Knapp, B., Zaretsky, J., Wan, F., & Adkins, D. (2025). Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. Cancers, 17(21), 3568. https://doi.org/10.3390/cancers17213568

Chicago Style (17th ed.) Citation

Oppelt, Peter, Jessica Ley, Christine Auberle, Brendan Knapp, Jesse Zaretsky, Fei Wan, and Douglas Adkins. "Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial." Cancers 17, no. 21 (2025): 3568. https://doi.org/10.3390/cancers17213568.

MLA (9th ed.) Citation

Oppelt, Peter, et al. "Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial." Cancers, vol. 17, no. 21, 2025, p. 3568, https://doi.org/10.3390/cancers17213568.